Max Chat
Company Analysis Celularity Inc.
1. Summary
Advantages
- Price (1.75 $) is less than fair price (2.56 $)
Disadvantages
- Dividends (0%) are below the sector average (0.5261%).
- The stock's return over the last year (-39.24%) is lower than the sector average (-2.01%).
- Current debt level 21.88% has increased over 5 years from 9.64%.
- The company's current efficiency (ROE=-232.51%) is lower than the sector average (ROE=14.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Celularity Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.8% | -46.6% | 3.2% |
| 90 days | 6.7% | -0.7% | 13% |
| 1 year | -39.2% | -2% | 12.8% |
CELU vs Sector: Celularity Inc. has significantly underperformed the "Healthcare" sector by -37.22% over the past year.
CELU vs Market: Celularity Inc. has significantly underperformed the market by -52.08% over the past year.
Stable price: CELU is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CELU with weekly volatility of -0.7545% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (1.75 $) is lower than the fair price (2.56 $).
Price significantly below the fair price: The current price (1.75 $) is 46.3% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (63.23).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (89.86).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.15) is lower than that of the sector as a whole (18.83).
P/BV vs Market: The company's P/BV (5.15) is lower than that of the market as a whole (9.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.8398) is lower than that of the sector as a whole (32.67).
P/S vs Market: The company's P/S indicator (0.8398) is lower than that of the market as a whole (10.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-1.92) is lower than that of the sector as a whole (274.42).
EV/Ebitda vs Market: The company's EV/Ebitda (-1.92) is lower than that of the market as a whole (50.71).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -14.44% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-14.44%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (-232.51%) is lower than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (-232.51%) is lower than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (-41.86%) is lower than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (-41.86%) is lower than that of the market as a whole (6.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5261%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
